More articles from Asthma

The impact of anti-eosinophilic therapy on exercise capacity and inspiratory muscle strength in patients with severe asthma
Elisa Franceschi, Nora Drick, Jan Fuge, Pierachille Santus, Bettina Fischer, Moritz Kayser, Tobias Welte, Hendrik Suhling

ERJ Open Research Mar 2023, 9 (2) 00341-2022; DOI: 10.1183/23120541.00341-2022
Distribution of type 2 biomarkers and association with severity, clinical characteristics and comorbidities in the BREATHE real-life asthma population
Laurits Frøssing, Ditte K. Klein, Morten Hvidtfeldt, Nicolai Obling, Gunilla Telg, Jonas S. Erjefält, Uffe Bodtger, Celeste Porsbjerg

ERJ Open Research Mar 2023, 9 (2) 00483-2022; DOI: 10.1183/23120541.00483-2022
Development and validation of a predictive model combining patient-reported outcome measures, spirometry and exhaled nitric oxide fraction for asthma diagnosis
Gilles Louis, Florence Schleich, Michèle Guillaume, Delphine Kirkove, Halehsadat Nekoee Zahrei, Anne-Françoise Donneau, Monique Henket, Virginie Paulus, Françoise Guissard, Renaud Louis, Benoit Pétré

ERJ Open Research Jan 2023, 9 (1) 00451-2022; DOI: 10.1183/23120541.00451-2022
Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
Nastaran Mues, Richard J. Martin, Rafeul Alam, Niccolette Schaunaman, Kris Genelyn Dimasuay, Christena Kolakowski, Clyde J. Wright, Lijun Zheng, Hong Wei Chu

ERJ Open Research Jan 2023, 9 (1) 00474-2022; DOI: 10.1183/23120541.00474-2022
Adverse perception of cough in patients with severe asthma: a discrete choice experiment
Joshua Holmes, Vikki O'Neill, Lorcan P. McGarvey, Liam G. Heaney

ERJ Open Research Jan 2023, 9 (1) 00442-2022; DOI: 10.1183/23120541.00442-2022
Early-life risk factors for development of asthma from 8 to 28 years of age: a prospective cohort study
Linnéa Hedman, Linnéa Almqvist, Anders Bjerg, Martin Andersson, Helena Backman, Matthew S. Perzanowski, Eva Rönmark

ERJ Open Research Oct 2022, 8 (4) 00074-2022; DOI: 10.1183/23120541.00074-2022
Past asthma exacerbation in children predicting future exacerbation: a systematic review
Rachel Lowden, Steve Turner

ERJ Open Research Oct 2022, 8 (4) 00174-2022; DOI: 10.1183/23120541.00174-2022
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
Anne-Noelle Frix, Liam G. Heaney, Barbro Dahlén, Florin Mihaltan, Svetlana Sergejeva, Sanja Popović-Grle, Vratislav Sedlak, Lauri Lehtimäki, Arnaud Bourdin, Stephanie Korn, Eleftherios Zervas, Zsuzsanna Csoma, Dora Lúðvíksdóttir, Marcus Butler, Giorgio Walter Canonica, Ineta Grisle, Kristina Bieksiene, Anneke Ten Brinke, Piotr Kuna, Claudia Chaves Loureiro, Natalia M. Nenasheva, Zorica Lazic, Sabina Škrgat, David Ramos-Barbon, Joerg Leuppi, Bilun Gemicioglu, Apostolos Bossios, Celeste M. Porsbjerg, Elisabeth H. Bel, Ratko Djukanovic, Renaud Louis

ERJ Open Research Oct 2022, 8 (4) 00273-2022; DOI: 10.1183/23120541.00273-2022
Complete response to anti-interleukin-5 biologics in a real-life setting: results from the nationwide Danish Severe Asthma Register
Marianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, Ole Hilberg, Sofie Lock-Johansson, Kjell Erik Julius Håkansson, Truls Sylvan Ingebrigtsen, Claus Rikard Johnsen, Linda Makowska Rasmussen, Anna von Bülow, Karin Dahl Assing, Johannes Martin Schmid, Charlotte Suppli Ulrik, Celeste Porsbjerg

ERJ Open Research Oct 2022, 8 (4) 00238-2022; DOI: 10.1183/23120541.00238-2022
SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)
Stephen G. Noorduyn, Christina Qian, Karissa M. Johnston, Mena Soliman, Manisha Talukdar, Brandie L. Walker, Paul Hernandez, Erika Penz

ERJ Open Research Jul 2022, 8 (3) 00140-2022; DOI: 10.1183/23120541.00140-2022

Main menu

User menu

Search

More articles from Asthma

Pages

Contact us